Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer
Clinical trial NCT02317016 · COMPLETED
Trial details
- NCT number
- NCT02317016
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-10
- Primary completion
- 2015-07-11
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.